PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $165,000 | +10.7% | 43,483 | +48.4% | 0.00% | +33.3% |
Q4 2019 | $149,000 | +0.7% | 29,301 | -0.0% | 0.00% | 0.0% |
Q3 2019 | $148,000 | -17.3% | 29,315 | +1.0% | 0.00% | 0.0% |
Q2 2019 | $179,000 | +32.6% | 29,026 | +0.0% | 0.00% | +50.0% |
Q1 2019 | $135,000 | +10.7% | 29,018 | +0.1% | 0.00% | 0.0% |
Q4 2018 | $122,000 | -3.2% | 28,992 | +44.8% | 0.00% | 0.0% |
Q3 2018 | $126,000 | +0.8% | 20,019 | +28.4% | 0.00% | 0.0% |
Q2 2018 | $125,000 | – | 15,594 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Phocas Financial Corp. | 1,033,328 | $6,376,000 | 0.68% |
ARDSLEY ADVISORY PARTNERS LP | 650,000 | $4,011,000 | 0.63% |
Worth Venture Partners, LLC | 138,357 | $853,000 | 0.47% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,242,503 | $13,836,000 | 0.46% |
HIGHLAND CAPITAL MANAGEMENT LP | 716,880 | $4,423,000 | 0.26% |
FARALLON CAPITAL MANAGEMENT LLC | 5,543,386 | $34,203,000 | 0.22% |
Point72 Asset Management, L.P. | 5,858,749 | $36,148,000 | 0.19% |
PINNACLE ASSOCIATES LTD | 1,298,723 | $8,013,000 | 0.19% |
Fosun International Ltd | 472,580 | $2,750,000 | 0.18% |
J. Goldman & Co LP | 400,000 | $2,468,000 | 0.17% |